Cargando…
Serum Mac‐2 binding protein level predicts the development of liver‐related events and colorectal cancer in patients with NAFLD
We previously demonstrated that Mac‐2 binding protein (M2BP) is a useful biomarker for nonalcoholic fatty liver disease (NAFLD), particularly NAFLD fibrosis prediction. In the present study, we investigated the prognostic value of M2BP in patients with NAFLD. A total of 506 patients with biopsy‐conf...
Autores principales: | Kamada, Yoshihiro, Nakahara, Takashi, Munekage, Kensuke, Fujii, Hideki, Sawai, Yoshiyuki, Doi, Yoshinori, Ono, Masafumi, Hyogo, Hideyuki, Sumida, Yoshio, Morishita, Koichi, Asuka, Tatsuya, Ouchida, Tsunenori, Imai, Yasuharu, Miyoshi, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234644/ https://www.ncbi.nlm.nih.gov/pubmed/35478356 http://dx.doi.org/10.1002/hep4.1934 |
Ejemplares similares
-
The FIB-4 Index Predicts the Development of Liver-Related Events, Extrahepatic Cancers, and Coronary Vascular Disease in Patients with NAFLD
por: Kamada, Yoshihiro, et al.
Publicado: (2022) -
Use of Mac‐2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis
por: Kamada, Yoshihiro, et al.
Publicado: (2017) -
Challenges in the Application of Glyco-Technology to Hepatitis B Virus Therapy and Diagnosis
por: Ouchida, Tsunenori, et al.
Publicado: (2021) -
Serum Mac-2 Binding Protein Levels Associate with Metabolic Parameters and Predict Liver Fibrosis Progression in Subjects with Fatty Liver Disease: A 7-Year Longitudinal Study
por: Kamada, Yoshihiro, et al.
Publicado: (2020) -
Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS
por: Ochi, Tsunehiro, et al.
Publicado: (2017)